Rchr
J-GLOBAL ID:200901076805895246
Update date: Aug. 31, 2024
Sakate Ryuichi
サカテ リュウイチ | Sakate Ryuichi
Affiliation and department:
Job title:
Deputy Director
Other affiliations (2):
-
National Institutes of Biomedical Innovation, Health and Nutrition
Laboratory of Rare Disease Information and Resource Library, Center for Intractable Diseases and ImmunoGenomics (CiDIG)
Project Leader
-
National Institutes of Biomedical Innovation, Health and Nutrition
Platform of Therapeutics for Rare Disease, Center for Intractable Diseases and ImmunoGenomics (CiDIG)
Project Leader
Research field (1):
Systems genomics
Research theme for competitive and other funds (2):
- 2020 - 2023 Construction of Database of Drug Development for Intractable/Rare Diseases
- 2009 - 2011 Relations between characteristic features of biological dynamic pathway models and gene polymorphisms or gene functions
Papers (36):
-
Mao Tanabe, Makoto Hirata, Ryuichi Sakate. Trends in drug development for rare and intractable diseases based on the KEGG NETWORK. NAR Molecular Medicine. 2024
-
Mao Tanabe, Ryuichi Sakate, Jun Nakabayashi, Kyosuke Tsumura, Shino Ohira, Kaoru Iwato, Tomonori Kimura. A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases. Scientific Reports. 2023. 13. 1
-
Naoki Nakagawa, Tomonori Kimura, Ryuichi Sakate, Takehiko Wada, Kengo Furuichi, Hirokazu Okada, Yoshitaka Isaka, Ichiei Narita. Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records. Scientific reports. 2023. 13. 1. 14771-14771
-
Naoki Nakagawa, Tomonori Kimura, Ryuichi Sakate, Yoshitaka Isaka, Ichiei Narita. Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records. Clinical and experimental nephrology. 2023
-
Yusuke Tsukamoto, Yumi Nakamura, Makoto Hirata, Daisuke Okuzaki, Ryuichi Sakate, Tomonori Kimura. GCN2 kinase-mediated upregulation of ubiquitin C maintains intracellular glutamine level and tRNAGln (CUG) charging under amino acid starvation. FEBS letters. 2023. 597. 12. 1638-1650
more...
MISC (33):
Lectures and oral presentations (15):
-
難病創薬に向けた情報解析 〜難治性疾患研究開発・支援センターの取り組み〜
(第15回 霊長類医科学フォーラム 2019)
-
難病・希少疾患の疾患オントロジー
(トーゴーの日シンポジウム2019 2019)
-
DDrare -難病創薬と標的遺伝子・パスウェイのデータベース-
(トーゴーの日シンポジウム2019 2019)
-
難病・希少疾患の創薬情報の解析
(大阪大学薬学研究科PRP/PharmaTrain教育コース 2018)
-
DDrare: Database of Drug Development for Rare Diseases and Its Data Analysis - Multiple Drugs Tested in a Clinical Trial -
(The 41st Annual Meeting of the Molecular Biology Society of Japan 2018)
more...
Professional career (1):
Association Membership(s) (2):
THE MOLECULAR BIOLOGY SOCIETY OF JAPAN
, SOCIETY OF EVOLUTIONARY STUDIES
Return to Previous Page